Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Acumen Pharmaceuticals Inc (ABOS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Acumen Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.250 +0.030    +0.93%
01/05 - Closed. Currency in USD ( Disclaimer )
After Hours
3.350
+0.100
+3.077%
18:27:30 - Real-time Data
  • Volume: 195,459
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.145 - 3.370
Type:  Equity
Market:  United States
Acumen Pharmaceuticals 3.250 +0.030 +0.93%

ABOS Recent Sentiments

 
This page features our users' sentiments regarding the Acumen Pharmaceuticals Inc stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 30, 2024 George Lathrop   3.180 +2.20%
Apr 29, 2024 Fernando Perez   3.170 Apr 29, 2024 @ 3.290 +3.79%
Apr 15, 2024 Fernando Perez   3.660 Apr 15, 2024 @ 3.630 -0.82%
Mar 30, 2024 Fernando Perez   3.910 Apr 01, 2024 @ 3.860 -1.28%
Mar 26, 2024 Dirgantara 3   3.600 Apr 19, 2024 @ 3.150 -12.50%
Mar 25, 2024 기선 김   4.390 Mar 25, 2024 @ 4.340 -1.14%
Feb 13, 2024 paul conde   3.140 Feb 19, 2024 @ 3.280 +4.46%
Dec 14, 2023 jitesh patel   2.960 Jan 05, 2024 @ 4.020 +35.81%
Oct 27, 2023 Suhar Yanto   2.910 Nov 30, 2023 @ 2.250 -22.68%
Oct 06, 2023 Gordan Black   4.440 Nov 30, 2023 @ 2.250 -49.32%
Jul 18, 2023 Samuel Vuistiner   7.420 Jul 19, 2023 @ 7.540 +1.62%
Jul 17, 2023 Louis Erwee   9.680 Nov 30, 2023 @ 2.250 -76.76%
Jul 17, 2023 Charles Crewe   9.670 Nov 30, 2023 @ 2.250 +76.73%
Jul 17, 2023 Giulio Cocci   9.720 Jul 18, 2023 @ 9.720 0.00%
Jul 17, 2023 david de neve   9.390 Nov 30, 2023 @ 2.250 -76.04%
Jul 17, 2023 שוהם סבתי   10.180 Sep 13, 2023 @ 5.530 -45.68%
Jul 17, 2023 Charles Crewe   10.410 Jul 17, 2023 @ 9.680 +7.01%
Mar 24, 2023 Alexander Schmaranzer   3.900 Apr 14, 2023 @ 3.740 -4.10%
Mar 07, 2023 Carl Michael Ashanti   5.560 Mar 31, 2023 @ 4.060 -26.98%
Dec 19, 2022 Carl Michael Ashanti   5.490 Jan 13, 2023 @ 6.240 +13.66%
Sep 28, 2022 Tatiana Shuginova   9.690 Oct 21, 2022 @ 7.640 +21.16%
Sep 28, 2022 Mateusz Cempa   9.730 Oct 21, 2022 @ 7.640 +21.48%
Sep 28, 2022 Ankit Ak   9.360 Oct 21, 2022 @ 7.640 -18.38%
Sep 28, 2022 Cruzeiro dos Santos   9.120 Oct 03, 2022 @ 9.540 -4.61%
Sep 28, 2022 Fa Gi   9.000 Oct 21, 2022 @ 7.640 +15.11%
Sep 28, 2022 Michele Marroni   9.100 Oct 21, 2022 @ 7.640 +16.04%
Sep 28, 2022 Juan Gamisans   9.320 Oct 13, 2022 @ 8.100 +13.09%
Sep 28, 2022 Thomas Locrel   8.800 Oct 04, 2022 @ 9.450 -7.39%
Sep 28, 2022 Cevdet Tanrıseven   8.640 Oct 21, 2022 @ 7.640 -11.57%
Jul 25, 2022 Robbert Kuipers   5.320 Aug 01, 2022 @ 5.270 -0.94%
Jul 06, 2022 Robbert Kuipers   5.340 Jul 11, 2022 @ 6.120 +14.61%
Mar 28, 2022 David Nahmani   4.780 Apr 22, 2022 @ 4.110 -14.02%
Sep 07, 2021 רונן בן חמו   17.910 Oct 01, 2021 @ 15.270 -14.74%
Sep 07, 2021 Robbert Kuipers   18.040 Oct 01, 2021 @ 15.270 -15.35%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABOS Comments

Write your thoughts about Acumen Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email